Stock Research for FATE


Featured Broker: Ally Invest

Get the due diligence for another stock.


FATE Stock Chart & Research Data

The FATE chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the FATE chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


FATE Due diligence Resources & Stock Charts

The FATE stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View FATE Detailed Price Forecast - CNN Money CNN View FATE Detailed Summary - Google Finance
Yahoo View FATE Detailed Summary - Yahoo! Finance Zacks View FATE Stock Research & Analysis -

Stock Analysis

TradeIdeas View FATE Trends & Analysis - Trade-Ideas Barrons View FATE Major Holders - Barrons
NASDAQ View FATE Call Transcripts - NASDAQ Seeking View FATE Breaking News & Analysis - Seeking Alpha
Spotlight View FATE Annual Report - OTC Report View FATE OTC Short Report -
TradeKing View FATE Fundamentals - TradeKing Charts View FATE SEC Filings - Bar Chart
WSJ View Historical Prices for FATE - The WSJ Morningstar View Performance/Total Return for FATE - Morningstar
MarketWatch View the Analyst Estimates for FATE - MarketWatch CNBC View the Earnings History for FATE - CNBC
StockMarketWatch View the FATE Earnings - StockMarketWatch MacroAxis View FATE Buy or Sell Recommendations - MacroAxis
Bullish View the FATE Bullish Patterns - American Bulls Short Pains View FATE Short Pain Metrics -

Social Media Mentions

StockTwits View FATE Stock Mentions - StockTwits PennyStocks View FATE Stock Mentions - PennyStockTweets
Twitter View FATE Stock Mentions - Twitter Invest Hub View FATE Investment Forum News - Investor Hub
Yahoo View FATE Stock Mentions - Yahoo! Message Board Seeking Alpha View FATE Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for FATE - Insider Cow View Insider Transactions for FATE - Insider Cow
CNBC View FATE Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for FATE - OTC Markets
Yahoo View Insider Transactions for FATE - Yahoo! Finance NASDAQ View Institutional Holdings for FATE - NASDAQ

Stock Charts

FinViz View FATE Stock Insight & Charts - StockCharts View FATE Investment Charts -
BarChart View FATE Stock Overview & Charts - BarChart Trading View View FATE User Generated Charts - Trading View

Latest Financial News for FATE

Free Pre-Market Technical Pulse on FibroGen and Three More Biotech Stocks
Posted on Tuesday July 10, 2018

LONDON, UK / ACCESSWIRE / July 10, 2018 / If you want a free Stock Review on FGEN sign up now at Pre-market, evaluates EyeGate Pharmaceuticals Inc. (NASDAQ: EYEG), EyePoint Pharmaceuticals Inc. (NASDAQ: EYPT), Fate Therapeutics Inc. (NASDAQ: FATE), and FibroGen Inc. (NASDAQ: FGEN).

3 Sectors to Buy in a Trade War
Posted on Thursday June 21, 2018

A full-blown trade war could test the resiliency of the nine-year bull market, with key groups exposed to a major correction, but a handful of sectors could thrive in the challenging conditions and find their way to new highs.

TransEnterix Stock Rose 5.6% on Friday and Early on June 4
Posted on Monday June 04, 2018

TransEnterix (TRXC) is a US-based medical device company that focuses on digitizing the interfaces between the surgeon and the patient. The stock price increased ~5.6% and closed at $3.75 on June 1. On May 31, TransEnterix announced that Louisiana State University Health New Orleans School of Medicine purchased the Senhance Surgical System, which was developed by TransEnterix.

Fate Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference
Posted on Friday June 01, 2018

SAN DIEGO, June 01, 2018-- Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to the development of programmed cellular immunotherapies for cancer and immune disorders, announced ...

Stock Market & Investing Books

Enter a stock symbol to view the stock details.